Cargando…

O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis

BACKGROUND: Fatigue is common in children and adolescents with multiple sclerosis (MS) and its aetiology is assumed to be multifactorial, however, its relationship to sleep quality in this population remains unknown. This study aims to examine the prevalence of fatigue and sleep disturbance in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, J, Yiu, E, Vandeleur, M, Adams, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109175/
http://dx.doi.org/10.1093/sleepadvances/zpab014.046
_version_ 1785027004162113536
author Tran, J
Yiu, E
Vandeleur, M
Adams, A
author_facet Tran, J
Yiu, E
Vandeleur, M
Adams, A
author_sort Tran, J
collection PubMed
description BACKGROUND: Fatigue is common in children and adolescents with multiple sclerosis (MS) and its aetiology is assumed to be multifactorial, however, its relationship to sleep quality in this population remains unknown. This study aims to examine the prevalence of fatigue and sleep disturbance in this population and their relationship to mood, quality of life, physical activity, and MS disease characteristics. METHODS: Children with pediatric onset multiple sclerosis (POMS) aged 0–18 were recruited. Subjective sleep quality was assessed by the Pediatric Daytime Sleepiness Scale (PDSS), Sleep Disturbance Scale for Children (SDSC) and OSA-18. All children were referred for polysomnography (PSG) including transcutaneous CO2 and video monitoring. Fatigue was assessed using the PedsQL Multidimensional Fatigue Scale (PedsQL-MFS). Progress to date: Fifteen children with relapsing remitting MS (mean age 15.73±1.44, mean EDSS score 1.11±1.12) have been enrolled to date. 73% of children were fatigued according to the PedsQL-MFS (mean transformed score 52.04). 67% and 60% of children scored higher than the clinical cutoff for the PDSS (17.87) and SDSC (42.73) respectively. However, all children scored within the normal range for the OSA-18 (34.00). To date, eleven children have completed PSG. Intended outcome and impact: This is the first study utilising PSG to objectively assess sleep quality in children with POMS. Findings from this study will document the magnitude of sleep disturbance in this population and have implications for the management of fatigue and other related impairments observed in paediatric MS.
format Online
Article
Text
id pubmed-10109175
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101091752023-05-15 O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis Tran, J Yiu, E Vandeleur, M Adams, A Sleep Adv Oral Presentations BACKGROUND: Fatigue is common in children and adolescents with multiple sclerosis (MS) and its aetiology is assumed to be multifactorial, however, its relationship to sleep quality in this population remains unknown. This study aims to examine the prevalence of fatigue and sleep disturbance in this population and their relationship to mood, quality of life, physical activity, and MS disease characteristics. METHODS: Children with pediatric onset multiple sclerosis (POMS) aged 0–18 were recruited. Subjective sleep quality was assessed by the Pediatric Daytime Sleepiness Scale (PDSS), Sleep Disturbance Scale for Children (SDSC) and OSA-18. All children were referred for polysomnography (PSG) including transcutaneous CO2 and video monitoring. Fatigue was assessed using the PedsQL Multidimensional Fatigue Scale (PedsQL-MFS). Progress to date: Fifteen children with relapsing remitting MS (mean age 15.73±1.44, mean EDSS score 1.11±1.12) have been enrolled to date. 73% of children were fatigued according to the PedsQL-MFS (mean transformed score 52.04). 67% and 60% of children scored higher than the clinical cutoff for the PDSS (17.87) and SDSC (42.73) respectively. However, all children scored within the normal range for the OSA-18 (34.00). To date, eleven children have completed PSG. Intended outcome and impact: This is the first study utilising PSG to objectively assess sleep quality in children with POMS. Findings from this study will document the magnitude of sleep disturbance in this population and have implications for the management of fatigue and other related impairments observed in paediatric MS. Oxford University Press 2021-10-07 /pmc/articles/PMC10109175/ http://dx.doi.org/10.1093/sleepadvances/zpab014.046 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Sleep Research Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Oral Presentations
Tran, J
Yiu, E
Vandeleur, M
Adams, A
O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis
title O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis
title_full O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis
title_fullStr O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis
title_full_unstemmed O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis
title_short O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis
title_sort o047 sleep quality and fatigue in children and adolescents with multiple sclerosis
topic Oral Presentations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10109175/
http://dx.doi.org/10.1093/sleepadvances/zpab014.046
work_keys_str_mv AT tranj o047sleepqualityandfatigueinchildrenandadolescentswithmultiplesclerosis
AT yiue o047sleepqualityandfatigueinchildrenandadolescentswithmultiplesclerosis
AT vandeleurm o047sleepqualityandfatigueinchildrenandadolescentswithmultiplesclerosis
AT adamsa o047sleepqualityandfatigueinchildrenandadolescentswithmultiplesclerosis